title: Allogeneic bone marrow transplantation (BMT) in a patient with myelodysplastic syndrome (MDS) infected by hepatitis B virus (HBV) precore mutant: favorable outcome with slow tapering of immunosuppressive agents.
authors.forename: A
authors.initials: A
authors.lastname: Kikuchi
authors.forename: S
authors.initials: S
authors.lastname: Kagimoto
authors.forename: H
authors.initials: H
authors.lastname: Kishimoto
authors.forename: K
authors.initials: K
authors.lastname: Yamamoto
authors.forename: R
authors.initials: R
authors.lastname: Hanada
mesh_terms: D000293:Adolescent; D001706:Biopsy; D016026:Bone Marrow Transplantation; D005260:Female; D006509:Hepatitis B / Q000628:therapy* / Q000821:virology; D006515:Hepatitis B virus / Q000235:genetics / Q000302:isolation & purification*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008099:Liver / Q000378:metabolism / Q000473:pathology; D009154:Mutation; D009190:Myelodysplastic Syndromes / Q000628:therapy* / Q000821:virology; D014184:Transplantation, Homologous; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents